Big Vencor PACS order boosts Olicon's revenuesA major order for PACS technology from long-time customer Vencor has helped spur Olicon Imaging Systems to sharply higher revenue growth for the first six months of 1997. The Aliso Viejo, CA, company
A major order for PACS technology from long-time customer Vencor has helped spur Olicon Imaging Systems to sharply higher revenue growth for the first six months of 1997. The Aliso Viejo, CA, company this month reported that its PACS sales for the first half of 1997 have increased 128% over the first six months of last year. Exact numbers are not available for the company because it is privately held.
Olicon executives reported that Vencor, a hospital network based in Louisville, KY, has ordered over $3 million in PACS equipment this year, bringing the total value of equipment it has purchased from Olicon to $6 million. From a centralized reading facility in Louisville, Vencor radiologists interpret images for a nationwide network of 32 hospitals and 41 mobile vans.
The new order covers the integration of Olicon's teleradiology equipment with Vencor's RIS and its internally developed patient information system. The new equipment will also add 31 mobile vans and 27 hospitals to the Vencor PACS network.
Olicon also reports that it has received orders through its relationships with Fuji Medical Systems USA and Picker International. The three companies are collaborating on installations at Winthrop University Hospital in Mineola, NY, and Henry Mayo Newhall Hospital in Newhall, CA. Other recent installations by Olicon include networks at Norman Regional Hospital in Norman, OK, and Samaritan Health System in Phoenix.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.